Anne Whitaker is a seasoned Healthcare Executive with 28+ years of experience across multiple companies and geographies. She has a proven track record of building and leading high-performance teams to successfully commercialize pharmaceuticals, consumer products, and medical devices. 

Anne has been recognized in the pharmaceutical industry by FiercePharma as one of the top ‘25 Most Influential People in BioPharma’ in 2012 and 2013, and in 2014 as one of the top ‘25 Most Influential Women in BioPharma’. She was recently recognized by PharmaVoice as one of the ‘Top 100 most Inspiring Leaders in Healthcare’ and by Women, Inc as one of the most ‘Influential Corporate Directors’ in 2019. She is a member of the Women Corporate Directors, the Healthcare Businesswomen’s Association, the International Women’s Forum, and OnBoardNC. 

Also, Anne is the current Chairman of Aerami Therapeutics, She acts as an independent director on the board of Cree, Mallinckrodt, and UDG Healthcare, and serves on the Board of Trustees for the University of North Alabama, her alma mater. She is an active industry advisor to private equity and venture capital funds in the US and Europe. 

Anne served as the President of the North America Region Head, where she led the team to deliver ~$10B in net sales equaling > 30% of the net sales. She served as the CEO and President of Synta Pharmaceuticals, in 2014 and 2015 and joined Bausch Health as an Ex. VP and Company Group Chairman for the Branded Pharmaceuticals segment in mid-2015. Later, she served as the CEO and President of Novoclem Therapeutics, Inc. She holds a Bachelor of Science degree in chemistry from the University of North Alabama.